Blog Articles
Hospital Employed Physician-Does your malpractice insurance cover usage of non-FDA approved device?
Blog Post Summary: Why You Need Medical Malpractice Insurance Medical malpractice insurance, also known as professional liability insurance, is essential for every physician, regardless of their specialty or practice location. While some states legally mandate malpractice insurance for all physicians, others strongly recommend it, and most employers insist on it. The cost of malpractice insurance is a minor expense compared to potential liabilities in the event of a lawsuit.
The U.S. Department of Health and Human Services (HHS) settles landmark case related to a ransomware cyber-attack.
The U.S. Department of Health and Human Services (HHS), Office for Civil Rights (OCR), has settled a landmark case related to a ransomware cyber-attack. The $100,000 settlement with Doctors’ Management Services, a Massachusetts medical management company, is the first of its kind involving ransomware. The attack affected the electronic protected health information of over 200,000 individuals. The incident, involving the GandCrab ransomware, was reported to HHS in April 2019.
Is Novavax the Game-Changer for Long COVID and Autoimmune Patients?
The Novavax COVID-19 vaccine is gaining attention as a potential alternative for individuals with autoimmune conditions and those seeking relief from long COVID symptoms. Unlike mRNA vaccines, Novavax uses proteins instead of mRNA, and data suggests it may have milder side effects.
Study Finds Females and Young Adults Face Higher Risk of COVID-19 Vaccine Side Effects
Summary: A recent Japanese study published in Scientific Reports reveals that females and young adults are more susceptible to side effects following COVID-19 vaccinations. The research, conducted on 272 hospital employees who received the Pfizer vaccine as a second dose, indicates higher frequencies of vaccine-related side effects and prolonged recovery in women and younger individuals compared to their male and elderly counterparts.
FDA Approves Updated mRNA COVID-19 Vaccines Targeting Current Variants.
Summary: On September 11, 2023, the U.S. Food and Drug Administration (FDA) took action to approve and authorize emergency use of updated COVID-19 vaccines designed to better protect against currently circulating variants. The approved vaccines, manufactured by ModernaTX Inc. and Pfizer Inc., have been modified to include a monovalent component targeting the Omicron variant XBB.1.5.
Is Novavax as comparable in safety and effectiveness to mRNA vaccines?
The article discusses the Novavax COVID-19 vaccine and whether it’s worth the wait for individuals, particularly those with autoimmune diseases or specific concerns about mRNA vaccines. The Novavax vaccine, based on proteins rather than mRNA, has been in use since early 2022 in other countries. Some studies suggest that Novavax may have milder side effects compared to mRNA vaccines, making it an attractive option for certain individuals.
Amazon Professional Health Care Program approved listing of medical devices to sell.
Examples of permitted listings for only sellers participating in the Professional Health Care Program Products that are labeled for professional or prescription use only (Rx) may only be sold by sellers participating in Amazon’s Professional Health Care Program to appropriately licensed healthcare customers with Amazon Business accounts. Note: The following listings are prohibited for any seller not authorized to sell Rx medical devices through the Professional Health Care Program.
Errors in Laboratory Diagnostic testing: Causes and Remedial Strategies
Title: “Errors in Clinical Reasoning: Causes and Remedial Strategies“ Summary:The article discusses errors in clinical reasoning, with a focus on laboratory diagnostics, a field prone to mistakes due to its fast-paced and complex nature. While the overall frequency of laboratory errors is modest, ranging from 0.25% to 0.75%, the significant number of tests conducted makes even this small percentage noteworthy.
Biotech Slump Threatens Progress on Critical Drug Research
Summary: The biotech industry is facing a significant setback as funding challenges, rising interest rates, and pricing concerns lead to a decline in research and development (R&D) spending. Sangamo Therapeutics Inc., in response to economic challenges, has paused research on an experimental gene therapy for Fabry disease, affecting patients like Jerry Walter. The broader impact is visible as biotech companies cut back on R&D, leading to a decrease in new treatments and potential cures.
What’s next for dental practitioners after selling their practice.
This article highlights the challenges and considerations that arise for dental practitioners after selling their practice. The focus is on managing the proceeds effectively, especially in the face of potential market volatility. The article draws parallels between current economic conditions and those of the 1970s, emphasizing concerns about a potential market downturn. It urges practitioners to be cautious and informed in their financial decisions, especially with the loss of regular income post-sale.